The Treatment of Bipolar Depression: From Pills to Words-Presentation Q&A

Video Transcription

Video Summary

In this video, Dr. Rakofsky discusses modifications to monitoring protocols during the COVID-19 pandemic, specifically regarding blood work for lithium levels. Initially, blood work was done every six months due to patients' reluctance to visit clinics. However, some clinics have found ways to safely provide lab draws. Telehealth has been utilized for patient visits, allowing for continued monthly or every two-month appointments. Dr. Rakofsky also discusses the combination of Lamotrigine and Latuda for bipolar treatment, the role of family members in helping with medication adherence, the use of extended-release lithium, and strategies for assessing unipolar versus bipolar depression. Gabapentin is recommended for anxiety in bipolar patients, while Trileptal is not commonly used for bipolar depression. Topiramate may be useful for ultra-rapid cycling patients. Ketamine has shown effectiveness in bipolar depression, but there is a risk of psychosis. Treatment considerations for Bipolar II and ADHD include the use of antidepressants with caution and the effectiveness of stimulants when used with a mood stabilizer. Non-stimulant options are also available for ADHD treatment in Bipolar patients.

Keywords

monitoring protocols

COVID-19 pandemic

blood work

Lamotrigine

Latuda